Technical Analysis for MDWD - MediWound Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| 20 DMA Resistance | Bearish | -0.84% | |
| MACD Bullish Signal Line Cross | Bullish | -0.84% | |
| Pocket Pivot | Bullish Swing Setup | -0.84% | |
| Volume Surge | Other | -0.84% | |
| 20 DMA Resistance | Bearish | 3.43% | |
| Up 3 Days in a Row | Strength | 1.12% | |
| NR7 | Range Contraction | 5.41% |
| Alert | Time |
|---|---|
| Rose Above 20 DMA | about 7 hours ago |
| Down 2 % | about 7 hours ago |
| Down 1% | about 7 hours ago |
| Up 1% | about 7 hours ago |
| 10 DMA Support | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/13/2024
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Acute Pain Burns Connective Tissue Medical Emergencies Necrosis Yavne
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Acute Pain Burns Connective Tissue Medical Emergencies Necrosis Yavne
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.86 |
| 52 Week Low | 7.1 |
| Average Volume | 78,665 |
| 200-Day Moving Average | 12.85 |
| 50-Day Moving Average | 16.73 |
| 20-Day Moving Average | 15.54 |
| 10-Day Moving Average | 14.70 |
| Average True Range | 0.93 |
| RSI (14) | 47.64 |
| ADX | 19.45 |
| +DI | 18.86 |
| -DI | 22.31 |
| Chandelier Exit (Long, 3 ATRs) | 14.77 |
| Chandelier Exit (Short, 3 ATRs) | 15.56 |
| Upper Bollinger Bands | 17.69 |
| Lower Bollinger Band | 13.40 |
| Percent B (%b) | 0.46 |
| BandWidth | 27.55 |
| MACD Line | -0.50 |
| MACD Signal Line | -0.58 |
| MACD Histogram | 0.0799 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.32 | ||||
| Resistance 3 (R3) | 16.34 | 16.04 | 16.17 | ||
| Resistance 2 (R2) | 16.04 | 15.81 | 16.04 | 16.11 | |
| Resistance 1 (R1) | 15.72 | 15.66 | 15.88 | 15.70 | 16.06 |
| Pivot Point | 15.42 | 15.42 | 15.51 | 15.42 | 15.42 |
| Support 1 (S1) | 15.10 | 15.19 | 15.26 | 15.08 | 14.72 |
| Support 2 (S2) | 14.80 | 15.04 | 14.80 | 14.67 | |
| Support 3 (S3) | 14.48 | 14.80 | 14.62 | ||
| Support 4 (S4) | 14.46 |
